(Q21261865)

18 August 2022

Stephanie Roll

2

Stephanie

Roll

1 reference

18 August 2022

Christoph Schwarzbach

3

Christoph

Schwarzbach

1 reference

18 August 2022

Christoph Vauth

4

Christoph

Vauth

1 reference

18 August 2022

Stefan N Willich

5

Stefan N

Willich

1 reference

Creative Commons Attribution 2.0 Generic

18 August 2022

language of work or name

English

0 references

publication date

17 March 2010

4 references

25 April 2019

6 August 2019

22 October 2019

22 October 2020

4 references

25 April 2019

6 August 2019

22 October 2019

22 October 2020

10

0 references

issue

1

0 references

page(s)

14

0 references

copyright license

4 references

25 April 2019

6 August 2019

22 October 2019

on focus list of Wikimedia project

22 October 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

The Hawthorne Effect: a randomised, controlled trial

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

A rating scale for depression

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Ginkgo biloba for cognitive impairment and dementia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

19 March 2017

1 reference

https://api.crossref.org/works/10.1186/1471-2318-10-14

Development and validation of a geriatric depression screening scale: a preliminary report

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

A New Depression Scale Designed to be Sensitive to Change

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Ginkgo biloba for prevention of dementia: a randomized controlled trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Checklist for the qualitative evaluation of clinical studies with particular focus on external validity and model validity

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Development and validation of the geriatric evaluation by relatives rating instrument (GERRI).

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

A new rating scale for Alzheimer's disease.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Measurement of quality-of-life changes in patients with Alzheimer's disease.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial.

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

Ginkgo biloba extract and preventing Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

A comment on Ginkgo biloba for mild to moderate dementia in a community setting by McCarney et al.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

Factor structure and scoring of the SKT test battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-10-14

Identification of adverse drug reactions by evaluation of a prescription database, demonstrated for "risk of bleeding".

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

The Alzheimer's disease activities of daily living international scale (ADL-IS).

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846949

Assessing quality of life in older adults with cognitive impairment

29 November 2018

1 reference

12 December 2020

Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761

1 reference

12 December 2020

Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial

1 reference

12 December 2020

[External validity of clinical trials for treatment of dementia with ginkgo biloba extracts]

1 reference

12 December 2020

An example for an underpowered study: a comment on Ginkgo biloba for mild to moderate dementia in a community setting by McCarney et al

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2318-10-14

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2318-10-14

1 reference

9 September 2019

Fatcat ID

release_lrwrjeqk75fmvdhg5v3egue6xu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lrwrjeqk75fmvdhg5v3egue6xu

24 November 2022

mapped directly with Wikidata item

1 reference

1 reference

PubMed publication ID

20236541

1 reference